Remziye E. Wessel

Remziye E. Wessel

Auto-generated profile, based on publicly available information

Remziye E. Wessel

Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2024 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
RWRemziye E Wessel
Remziye E Wessel
NANardin Ageeb
Nardin Ageeb
JOJoseph M Obeid
Joseph M Obeid
IMIleana S Mauldin
Ileana S Mauldin
KGKate A Goundry
Kate A Goundry
MBMichael G. Brown
Michael G. Brown
Background: Major histocompatibility complex class I (MHC-I) loss is frequent in non-small cell lung cancer (NSCLC) rendering tumor cells resistant to T cell lysis. NK cells kill MHC-I-deficient tumor cells, and although previous work indicated their presence at NSCLC margins, they were functionally impaired. Within, we evaluated whether NK cell and CD8 T cell infiltration and activation vary with MHC-I expression. Methods: We used single-stain immunohistochemistry (IHC) and Kaplan-Meier analysis to test the effect of NK cell and CD8 T cell infiltration on overall and disease-free survival. To delineate immune covariates of MHC-I-disparate lung cancers, we used multiplexed immunofluorescence (mIF) imaging followed by multivariate statistical modeling. To identify differences in infiltration and intercellular communication between IFNγ-activated and non-activated lymphocytes, we developed a computational pipeline to enumerate single-cell neighborhoods from mIF images followed by multivariate discriminant analysis. Results: Spatial quantitation of tumor cell MHC-I expression revealed intratumoral and intertumoral heterogeneity, which was associated with the local lymphocyte landscape. IHC analysis revealed that high CD56+ cell numbers in patient tumors were positively associated with disease-free survival (HR=0.58, p=0.064) and overall survival (OS) (HR=0.496, p=0.041). The OS association strengthened with high counts of both CD56+ and CD8+ cells (HR=0.199, p<1×10−3). mIF imaging and multivariate discriminant analysis revealed enrichment of both CD3+CD8+ T cells and CD3–CD56+ NK cells in MHC-I-bearing tumors (p<0.05). To infer associations of functional cell states and local cell–cell communication, we analyzed spatial single-cell neighborhood profiles to delineate the cellular environments of IFNγ+/– NK cells and T cells. We discovered that both IFNγ+ NK and CD8 T cells were more frequently associated with other IFNγ+ lymphocytes in comparison to IFNγ– NK cells and CD8 T cells (p<1×10–30). Moreover, IFNγ+ lymphocytes were most often found clustered near MHC-I+ tumor cells. Conclusions: Tumor-infiltrating NK cells and CD8 T cells jointly affected control of NSCLC tumor progression. Coassociation of NK and CD8 T cells was most evident in MHC-I-bearing tumors, especially in the presence of IFNγ. Frequent colocalization of IFNγ+ NK cells with other IFNγ+ lymphocytes in near-neighbor analysis suggests NSCLC lymphocyte activation is coordinately regulated.

8 October 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RWRemziye E. Wessel
Remziye E. Wessel
SDSepideh Dolatshahi
Sepideh Dolatshahi

8 September 2025 in Cellular and Molecular Bioengineering
Verified
Journal Article
Open access
PDF file
SLShay Ladd
Shay Ladd
ATAnne M. Talkington
Anne M. Talkington
MOMary O’sUllivan
Mary O’sUllivan
RBRobert W. Barnes
Robert W. Barnes
RWRemziye E. Wessel
Remziye E. Wessel
SDSepideh Dolatshahi
Sepideh Dolatshahi
Purpose: Despite the success of immune checkpoint inhibitors (ICIs) that target immunosuppressive interactions, treatment resistance remains a major clinical challenge. The tumor microenvironment is comprised of tumor, immune, and stromal cell types that communicate through secreted and cell surface proteins. This can be represented by a weighted, directed network where pairs of cell types communicate via multiple ligand-receptor interactions with varying strengths. Identifying interaction network motifs that are linked with outcome or evolve pre- to post-ICI presents a rational framework to identify combination therapeutic targets. Methods: Interaction inference was performed on publicly available single-cell RNA-sequencing data from melanoma patients. The constructed patient-specific networks were input to multivariate statistical learning approaches to identify network motifs that predicted response pre-treatment and that shifted pre- to post-treatment. Relevance of interactions was validated by (1) differential expression of related pathways in single cell RNA sequencing (scRNA-seq) data, (2) survival associations in an independent bulk RNA-seq dataset, and (3) repeated analyses of scRNA-seq data in a second cohort. Results: Immune-immune interactions with roles in T cell activation, chemotaxis, and adhesion were upregulated in patients who respond to therapy pre-treatment. Related pathways were perturbed in involved immune cells and expression of these genes was associated with improved survival. The interactome also distinguished pre- and post-treatment biopsies with high accuracy despite no significant differences in individual interactions. Analysis in the validation dataset with mixed responses pre-treatment recapitulated results from the discovery analyses. Conclusion: Unbiased analysis of interaction networks and their evolution is a powerful framework to guide prognostic indicators and novel combination targets to improve patient outcomes.

11 May 2026 in bioRxiv
Verified
Preprint
Open access
RWRemziye E. Wessel
Remziye E. Wessel
ASAnna Sawik
Anna Sawik
ABAbigail Boyette
Abigail Boyette
GMGuadalupe Martinez
Guadalupe Martinez
VKVanessa Kirschner
Vanessa Kirschner
SDSepideh Dolatshahi
Sepideh Dolatshahi
Maternal immunoglobulin G (IgG) transferred across the placenta is crucial for newborn immunity. IgG transfer efficiency modulated by Fc characteristics including subclass and glycosylation gives rise to diverse transfer profiles across the population, yet the molecular mechanisms driving this variation are incompletely understood. To disentangle multimodal molecular relationships driving population heterogeneity in maternal-fetal antibody transfer, we characterized placental and serological antibody features in matched human tissues from two geographically distinct cohorts. Unsupervised clustering of maternal clinical covariates in both cohorts revealed a distinct patient profile with reduced plasma C-reactive protein and pregravid BMI and enhanced transfer efficiency of IgG subclasses. Quantification of IgG Fc glycan structures in matched maternal and cord plasma by liquid chromatography-mass spectrometry revealed subclass-specific IgG glycosylation patterns which impacted placental transfer efficiency and correlated with these key clinical features. We profiled expression and colocalization of key Fc γ Receptors (FcγRs) by multiplex immunohistochemistry, revealing cell type-specific expression patterns. Variable FcγR expression across gestation was consistent in both cohorts, implicating FcγRs as key drivers of temporal antibody transfer dynamics. While FcγRs were not strongly variable across the clinical profiles, partial correlation analysis of matched samples controlling for gestational age and demographic covariates revealed correlations between FcγR expression frequencies and glycan- and subclass-specific transfer efficiency. These data systematically define multi-factorial regulatory networks of antibody transfer by placental Fc receptors and maternal IgG Fc characteristics, which are further modulated by clinical covariates. This study provides a basis for the rational design of prenatal vaccination strategies, administration schedules, and potential lifestyle interventions to improve maternal-fetal immunity.

22 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RWRemziye E. Wessel
Remziye E. Wessel
NANardin Ageeb
Nardin Ageeb
JOJoseph M. Obeid
Joseph M. Obeid
IMIleana S Mauldin
Ileana S Mauldin
KGKate A. Goundry
Kate A. Goundry
MBMichael G. Brown
Michael G. Brown
Background: MHC class I (MHC-I) loss is frequent in non-small cell lung cancer (NSCLC) rendering tumor cells resistant to T cell lysis. NK cells kill MHC-I-deficient tumor cells, and although previous work indicated their presence at NSCLC margins, they were functionally impaired. Within, we evaluated whether NK cell and CD8 T cell infiltration and activation vary with MHC-I expression. Methods: We used single-stain immunohistochemistry (IHC) and Kaplan-Meier analysis to test the effect of NK cell and CD8 T cell infiltration on overall and disease-free survival. To delineate immune covariates of MHC-I-disparate lung cancers, we used multiplexed immunofluorescence (mIF) imaging followed by multivariate statistical modeling. To identify differences in infiltration and intercellular communication between IFNγ-activated and non-activated lymphocytes, we developed a computational pipeline to enumerate single cell neighborhoods from mIF images followed by multivariate discriminant analysis Results: Spatial quantitation of tumor cell MHC-I expression revealed intra- and inter-tumoral heterogeneity, which was associated with the local lymphocyte landscape. IHC analysis revealed that high CD56 + cell numbers in patient tumors were positively associated with disease-free survival (DFS) (HR=0.58, p =0.064) and over-all survival (OS) (HR=0.496, p =0.041). The OS association strengthened with high counts of both CD56 + and CD8 + cells (HR=0.199, p <1×10 -3 ). mIF imaging and multivariate discriminant analysis revealed enrichment of both CD3 + CD8 + T cells and CD3 − CD56 + NK cells in MHC-I-bearing tumors (p<0.05). To infer associations of functional cell states and local cell-cell communication, we analyzed spatial single cell neighborhood profiles to delineate the cellular environments of IFNγ +/- NK cells and T cells. We discovered that both IFNγ + NK and CD8 T cells were more frequently associated with other IFNγ + lymphocytes in comparison to IFNγ − NK cells and CD8 T cells (p<1×10 -30 ). Moreover, IFNγ + lymphocytes were most often found clustered near MHC-I + tumor cells. Conclusions: Tumor-infiltrating NK cells and CD8 T cells jointly affected control of NSCLC tumor progression. Co-association of NK and CD8 T cells was most evident in MHC-I-bearing tumors, especially in the presence of IFNγ. Frequent co-localization of IFNγ + NK cells with other IFNγ + lymphocytes in near-neighbor analysis suggests NSCLC lymphocyte activation is coordinately regulated. What is already known on this topic: MHC-I loss occurs frequently in NSCLC and corresponds with waning immunity in the tumor microenvironment (TME). NK cells recognize “missing-self” targets and could be leveraged to target NSCLC tumors with MHC-I loss. While NK cell presence at tumor margins has been documented in NSCLC, they were shown to lose function in this environment. What this study adds: We developed spatial analysis pipelines leveraging the local heterogeneity of the TME at single cell resolution to test whether NK cells and T cells together contribute antitumoral immunity in NSCLC. We discovered that a high density of tumor-infiltrating NK cells corresponded with DFS, and this association was increased in patients with high coincident CD8 T cells, especially those in central tumor. Intriguingly, both cell types were found clustered together in MHC-I-bearing tumors, especially when both expressed IFNγ, suggesting coordinated lymphocyte activities may enhance immune control of NSCLC. How this study might affect research, practice, or policy: This study provides a rationale for developing novel immunotherapies that simultaneously increase NK and T cell anti-tumoral immunity. Associations linking NK cells with patient survival and increased immune effector activity in NSCLC, even in MHC-I-deficient tumors, further highlights the need to devise and deploy NK cell activating strategies which may be highly efficacious in CD8 T cell refractory NSCLC. Graphical

8 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
TZTomer Zohar
Tomer Zohar
RWRemziye E. Wessel
Remziye E. Wessel
ABAudrey L. Butler
Audrey L. Butler
MMMassimo Mangino
Massimo Mangino
SWSam Wadge
Sam Wadge
GAGalit Alter
Galit Alter
Antibodies are bifunctional molecules that play a critical role in immune defense, both through their ability to recognize a near infinite number of targets via gene rearrangement and somatic hypermutation in their antigen-binding (Fab) region, and by directing the functional activity of the immune system via subclass/isotype switching and post-translational modifications of the fragment crystallizable (Fc) region. While genetic biases in Fab evolution have been demonstrated, less is known about the genetic regulation of Fc-biology. Thus, we comprehensively profiled 227 pathogen-specific antibody Fc-profiles to 20 antigens from 16 viral and bacterial pathogens and 2 allergens across a cohort of 510 monozygotic and dizygotic female twins. The majority of subclass, isotype, Fc-receptor binding, and Fc-effector functions show a degree of heritability. GWAS of the top 45 heritable phenotypes identified five genomic regions that are significantly associated with humoral traits and account for up to 33% of variance. Co-expression analysis in transcriptomic data indicated involvement of cytokine signaling, T cell help, and antigen presentation by myeloid cells as key potential regulators of Fc-biology. Collectively, these data highlight potential genetic mechanisms that govern Fc-biology.